Search and analyze individual stocks with comprehensive metrics
DR AGARWALS HEALTH CARE L
Fundamental Score
DR AGARWALS HEALTH CARE L Share Price & Market Analysis
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of AGARWALEYE across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Strong Operating Margins (26.31%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.
Robust Profit Growth (150.83%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Strong Revenue Growth (20.80%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Consistent Growth Track Record (26.38% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Strong Profit Growth Track Record (41.72% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Strong Cash Generation (₹394.15 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Strong Institutional Confidence (FII+DII: 65.70%)
Observation: Significant professional investor participation indicates quality recognition.
Analysis: High institutional holding often signals thorough due diligence and quality business fundamentals.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
7 factors identified
Below-Average Return on Equity (4.76%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (9.99%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Premium Valuation Risk (P/E: 141.49x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Very Low ROE
Observation: Poor capital utilization and shareholder returns.
Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Very High P/E Ratio
Observation: Significant overvaluation risk present.
Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.
Loading Peer Comparison
Finding companies in the Hospital sector...
Financial Statements
Comprehensive financial data for DR AGARWALS HEALTH CARE L
About AGARWALEYE
Company Details
Market Information
Performance
AGARWALEYE Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of AGARWALEYE?
AGARWALEYE is currently trading at ₹520.00 with a gain of 0.00% today. The current market price (CMP) represents the last traded price of AGARWALEYE shares on the stock exchange. This price fluctuates throughout trading hours based on supply and demand. You can track real-time price movements, percentage changes, and trading volume in the header section.
What is the P/E ratio of AGARWALEYE and what does it mean?
AGARWALEYE has a P/E ratio of 141.49x compared to the industry average of 54.87x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹141 for every ₹1 of annual earnings. This is higher than the industry average, suggesting either growth premium or potential overvaluation.
How is AGARWALEYE performing according to Bull Run's analysis?
AGARWALEYE has a Bull Run fundamental score of 51.5/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability (ROE: 4.76%), growth metrics, valuation ratios, and financial health indicators. The score updates quarterly with new financial data and helps you quickly assess overall investment quality.
What sector and industry does AGARWALEYE belong to?
AGARWALEYE operates in the Healthcare Services industry. This sector classification helps understand the broader economic trends, regulatory framework, and competitive landscape affecting DR AGARWALS HEALTH CARE L. Companies in this industry typically face similar market dynamics, cyclical patterns, and macroeconomic factors. Understanding the industry context is crucial for peer comparison and assessing how sector-specific trends might impact the stock's performance.
What is Return on Equity (ROE) and why is it important for AGARWALEYE?
AGARWALEYE has an ROE of 4.76%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently DR AGARWALS HEALTH CARE L generates profits from shareholders' equity. An ROE of 5% means the company generates ₹5 profit for every ₹100 of shareholders' equity. This metric is crucial for assessing management's ability to create value for shareholders.
How is AGARWALEYE's debt-to-equity ratio and what does it indicate?
AGARWALEYE has a debt-to-equity ratio of 0.51, which indicates moderate leverage that should be monitored. This means the company has ₹51 of debt for every ₹100 of equity. Higher leverage can amplify returns during good times but increases bankruptcy risk during downturns.
What is AGARWALEYE's dividend yield and is it a good dividend stock?
AGARWALEYE offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested. The focus appears to be more on growth rather than dividend income. Dividend yield is calculated as annual dividend per share ÷ current share price × 100. Evaluate dividend consistency over 5+ years and free cash flow coverage for sustainability.
How has AGARWALEYE grown over the past 5 years?
AGARWALEYE has achieved 5-year growth rates of: Sales Growth 26.38%, Profit Growth 41.72%, and EPS Growth N/A%. This consistent double-digit growth indicates a strong business model and competitive positioning. Sales growth indicates market expansion, profit growth shows operational efficiency, and EPS growth directly impacts share price appreciation potential.
What is the promoter holding in AGARWALEYE and why does it matter?
Promoters hold 32.42% of AGARWALEYE shares, with 0.00% of promoter shares pledged. This promoter holding level suggests balanced ownership between management and public shareholders. Low pledging indicates financial stability of promoters. Recent change in promoter holding: -0.03%.
How does AGARWALEYE compare with its industry peers?
AGARWALEYE trades at P/E 141.49x vs industry average 54.87x, with ROE of 4.76% and ROCE of 9.99%. The stock trades at a premium to industry average, which may be justified by superior fundamentals. Peer comparison helps identify whether AGARWALEYE is outperforming its competitive set in profitability, growth, and valuation metrics.
What is AGARWALEYE's market capitalization and what category does it fall into?
AGARWALEYE has a market capitalization of ₹14564 crores, making it a Large-cap stock. Large-cap stocks offer stability and liquidity but typically slower growth. Market cap is calculated as current share price × total outstanding shares, representing the company's total market value.
What are the key financial ratios to consider for AGARWALEYE?
Key ratios for AGARWALEYE: ROE 4.76% (Needs improvement), ROCE 9.99%, P/E 141.49x, Debt-to-Equity 0.51, Interest Coverage 2.77x. These ratios help assess profitability (ROE, ROCE), valuation (P/E), financial health (D/E, Interest Coverage), and overall investment quality. Compare these with industry medians and historical trends for meaningful analysis.
How volatile is AGARWALEYE stock and what is its beta?
AGARWALEYE has a beta of N/A, which means it is less volatile than the market and offers defensive characteristics. Beta measures price volatility relative to the Nifty 50. Lower beta stocks provide stability during uncertain market conditions. Consider beta alongside your risk tolerance and portfolio diversification strategy.
What is the 52-week high and low for AGARWALEYE?
AGARWALEYE has a 52-week high of ₹N/A and low of ₹N/A. Currently trading at ₹520.00, the stock is within its annual trading range. Trading near highs indicates strong momentum but limited upside potential.
What are the key risks associated with investing in AGARWALEYE?
Key risks for AGARWALEYE include: Market volatility (Beta: N/A), financial leverage (Debt-to-Equity: 0.51), and operational challenges. The stock has a Fundamental Score of 51.5/100, indicating moderate risk requiring careful monitoring. Sector-specific risks in Healthcare Services include regulatory changes, economic cycles, and competitive pressures. Consider your risk tolerance, investment horizon, and portfolio diversification before investing. Past performance doesn't guarantee future results.
What is AGARWALEYE's operating profit margin and how has it trended?
AGARWALEYE has a 5-year average Operating Profit Margin (OPM) of 26.31%, which is excellent and indicates strong pricing power and cost control. Operating Profit Margin shows operational efficiency by measuring operating profit as a percentage of revenue. This strong margin indicates competitive advantages and operational leverage. Compare with industry peers to understand relative performance.
How is AGARWALEYE's quarterly performance in terms of sales and profit growth?
AGARWALEYE's recent quarterly performance shows YoY Sales Growth of 20.80% and YoY Profit Growth of 150.83%. This strong double-digit growth indicates excellent business momentum and management execution. Sales growth shows market demand while profit growth reveals operational efficiency and margin management.
What is the FII and DII holding pattern in AGARWALEYE?
AGARWALEYE has FII holding of 59.26% and DII holding of 6.44%, totaling 65.70% institutional ownership. High institutional holding indicates professional validation of business quality and growth prospects. Significant FII holding suggests global investor confidence and potential for index inclusion. Monitor quarterly changes in institutional holdings for investment flow trends and sentiment.